Expert review of anti-infective therapy
-
Expert Rev Anti Infect Ther · Apr 2013
ReviewCarbapenem-resistant Acinetobacter baumannii: epidemiology, surveillance and management.
Carbapenem-resistant Acinetobacter baumannii pose a significant threat to hospitalized patients, as therapeutic options are scarse. Alarmingly, rates of carbapenem-resistance in A. baumannii are on the rise and are slowly becoming a routine phenotype for this organism. This review focuses on infection control strategies for identification and control of A. baumannii, as well the available therapeutic options.